| Date | Title | Description |
| 30.06.2026 | Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact | Big-agency thinking with boutique agility, and impact you can measure. Independent firm sharpening decisions for life sciences marketers, the vendors selling to them, and the private equity firms weighing pharma assets. Where strategy meets... |
| 26.08.2025 | EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization | What You Should Know:
– EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
– The merger combines Waltz Health’s softw... |
| 26.02.2025 | Taboola Expands Beyond Native Ads with Realize | New Technology Platform Allows Taboola to Serve The Entire Performance Advertising Market, Delivering Outcomes at Scale Beyond Search and Social; Customers Include Babbel, eToro and More
HONG KONG, Feb. 26, 2025 /PRNewswire/ -- Taboola, a g... |
| 12.06.2024 | Beghou Consulting expands end-to-end life sciences commercialization capabilities | Beghou Consulting supports the end-to-end life sciences brand lifecycle with a blend of deep domain knowledge, data science and advanced analytics expertise, and powerful technology.
Rohit Gupta, Abhigya Jain and Nilanshu Sinha become new P... |
| 03.06.2024 | Beghou Consulting strengthens omnichannel and customer engagement capabilities with addition of new Partners | Beghou Consulting supports the end-to-end life sciences brand lifecycle with a blend of deep domain knowledge, data science and advanced analytics expertise, and powerful technology.
To help clients drive meaningful and differentiated engag... |
| 23.05.2024 | Spectrum Science CEO Jonathan Wilson Appoints Amy Hutnik as President | Spectrum Science, a full-service strategic platform offering integrated engagement, retention, marketing, communications and advisory services for the health and life science industries, today announced the appointment of Amy Hutnik to the ... |
| 06.03.2024 | Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia | - |
| 14.12.2023 | European Life Science Companies Join Forces With EVERSANA for Global Pharma Solutions | Driven to transform and unify commercialisation services for pharmaceutical brands entering or expanding into Europe, EVERSANA, a leading provider of commercialisation services to the life sciences industry, has united seven leading organiz... |
| 27.11.2023 | EVERSANA Expands Commitment to “Pharmatize” AI with Amazon Web Services | The new generative-AI powered offering comes just months after the organizations came together to determine novel ways to leverage AI to solve complex challenges facing life sciences
Building on a promise to “pharmatize” artificial intellig... |
| 02.06.2023 | EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally | BEIJING, June 2, 2023 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical Com... |
| 22.03.2023 | APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region | SINGAPORE, March 21, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named EVERSANA®, a pioneer of next-generation commercial services t... |
| 22.03.2023 | APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region | SINGAPORE, March 22, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named EVERSANA®, a pioneer of next-generation commercial services t... |
| 23.02.2023 | Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (A... | STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the t... |
| 22.02.2023 | EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific | SINGAPORE and CHICAGO, Feb. 22, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING, has been named to Vaul... |
| 08.02.2023 | EVERSANA CONSULTING Named a Best Boutique Consulting Firm by Vault For the Second Consecutive Year | CHICAGO, Feb. 8, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING has been named to Vault's 2023 Best Bo... |
| 13.07.2022 | EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region | CHICAGO and SINGAPORE, July 13, 2022 /PRNewswire/ -- EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and othe... |
| 04.05.2022 | Heart to Heart International and Intouch Group Partner to Place Much-Needed Labs in Safety-Net Clinics | Heart to Heart International Adopt-a-Lab
LENEXA, Kan. (PRWEB) May 04, 2022
Heart to Heart International (HHI), a global humanitarian organization focused on improving access to health, today announced a partnership with Intouch Group, an EV... |
| 17.03.2022 | EVERSANA unveils global price and market access solution NAVLIN by EVERSANA | Next generation price and market access platform combining data, software and insights into single ecosystem
CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences i... |
| 21.12.2021 | EVERSANA Completes Acquisition of Intouch Group, Adds the Premiere Digital-First Agency Network to the Market Leader in Next Generation Commercialization | EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced it has completed its acquisition of Intouch Group, a full-service global agency network serving the pharmaceutical industry. The ac... |
| 08.11.2021 | Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership | NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it... |
| 08.11.2021 | Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership | NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it... |
| 11.10.2021 | EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India | CHICAGO, Oct. 11, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, is celebrating its designation as a Great Place to Work® by the global authority in workplace culture... |
| 22.09.2021 | Proposals to cap Medicare Part B payments will limit outpatient access to CAR-T | The revolutionary life-extending approach to treating cancer known as CAR-T is under threat from a quotidian source: policy proposals to limit Medicare reimbursement in the outpatient setting to the average sales price of the treatment plus... |
| 17.08.2021 | Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment | |
| 26.07.2021 | EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies | |
| 22.06.2021 | EVERSANA Expands Medical Information and Integrated Compliance Services Across Europe | EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced a broad expansion of its integrated compliance services across Europe, including leading medical information (MI) operations across... |
| 21.06.2021 | EVERSANA :™ expands medical information and integrated compliance services across Europe | CHICAGO, June 21, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced a broad expansion of its integrated compliance services across Europe, including lead... |
| 14.06.2021 | GENinCode announces major US commercialisation partnership with EVERSANA | |
| 06.05.2021 | EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in new... | |
| 23.03.2021 | Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi™ for Mydriasis | NEW YORK & CHICAGO--(BUSINESS WIRE)--Mar 23, 2021--
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary Microdose Array Print (MAP™) platform technol... |
| 25.02.2021 | EVERSANA Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes | |
| 09.11.2020 | EVERSANA announces broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data to optimize real-time commercial services | |
| 16.09.2020 | EVERSANA launches ACTICS by EVERSANA™, the technology-enabled solution combining predictive analytics integrated with real-time commercial services to drive next best action in the life science sector... | |
| 09.09.2020 | EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners | |
| 14.07.2020 | Sharpening The Value And Definitions Of Digital And RWD: An Exchange Between Two Industry Leaders | President of Data & Analytics, at Eversana. |
| - | Shorla Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment. | Cambridge, Massachusetts, USA. 17 August, 2021. Seroba’s portfolio company, Shorla Pharma (‘Shorla’), a specialty pharmaceutical company and EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry,... |
